CRBU — Caribou Biosciences, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1619856 ·
Last close
$0.34
Market Cap
$36.81M
52W High
$2.49
52W Low
$0.32
ADV30
4,538,916
Next earnings
2026-11-11

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,607,000 — -27,642,000 -26,612,000 123,026,000 26,057,000 46,393,000
Jun 2026 1,499,000 — -25,339,000 -24,282,000 142,774,000 26,194,000 44,672,000
Mar 2026 2,397,000 — -26,280,000 -25,085,000 148,998,000 12,057,000 46,980,000
Dec 2025 3,941,000 — -28,453,000 -26,488,000 175,367,000 12,360,000 53,192,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-95,780,000
Investing CF
$71,748,000
Financing CF
$24,979,000
CapEx
$-606,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.08
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-645,882,000
Inventory
—
Receivables
$1,941,000
ST Investments
$86,120,000
EBIT TTM
$-109,472,000
Pretax Income TTM
$-103,953,000
Interest Exp TTM
—
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$9,444,000
EBITDA
$-102,892,000
Free Cash Flow
$-54,259,752
Enterprise Value
$-19,985,920
Total Cash
$94,800,000
Total Debt
$26,338,000
Shares Out
108,036,729
Trailing EPS
$-1.03
Book Value
$0.71
ROE
-93.8%
ROA
-41.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 11,159,000 -136,194,000 -148,125,000 175,367,000 53,192,000 122,175,000 -110,992,000
Dec 2024 9,994,000 -166,616,000 -149,105,000 313,313,000 60,362,000 252,951,000 -138,200,000
Dec 2023 34,477,000 -116,059,000 -102,070,000 432,209,000 63,808,000 368,401,000 -93,291,000
Dec 2022 13,851,000 -106,399,000 -99,421,000 373,765,000 72,894,000 300,871,000 -90,966,000

TTM Snapshot

Revenues TTM
$10,035,000
NetIncome TTM
$-103,403,000
OpCashFlow TTM
—
Assets (Latest)
$142,774,000
Forward EPS
$-0.90

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $0.50 · spot: $0.33 · call volume: 11 · put volume: 1
Expected Move to 2027-04-16: ±$0.25 (76.69%) — implied range $0.08 – $0.58 · ATM straddle on $0.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
TIL Instil Bio, Inc. $36.62M $5.40 —
TVGN Tevogen Inc. $37.05M $5.69 —
BKHA Black Hawk Acquisition Corp $35.93M $8.65 —
ELUT ELUTIA INC. $37.91M $0.85 —
KLRS Kalaris Therapeutics, Inc. $34.04M $1.43 —

News headlines (Yahoo Finance, 1h cache)

Caribou Biosciences (CRBU) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2026-11-12 13:55 · Yahoo
Caribou Biosciences (CRBU) Stock Sees Fair Value Cut After Clinical Programs Halted
2026-11-12 06:10 · Yahoo
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Beats Revenue Estimates
2026-11-06 00:00 · Yahoo
Caribou Biosciences Reports Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Caribou Biosciences, Inc. (CRBU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2026-11-04 14:00 · Yahoo
Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting
2026-11-04 14:00 · Yahoo
Caribou Biosciences (CRBU) Stock Fair Value Falls After Clinical Programs Are Halted
2026-10-28 06:16 · Yahoo
In the hunt for reverse merger targets, Caribou could be prized game
2026-10-08 15:23 · Yahoo
Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
2026-10-07 15:37 · Yahoo
CRBU Stock Crashes 35% Premarket — RBC Slashes Target By 90% After Caribou Scraps CAR-T Programs
2026-10-07 10:49 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.